Protein bonded with rabbit hemorrhagic disease virus VP60 protein and application thereof
A rabbit hemorrhagic disease, combined technology, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Example 1 In vitro combination of moesin MSN protein and virion
[0043] RHDV virus particles have the characteristics of agglutinating human blood "O" type red blood cells. 1.15 μg of recombinant MSN protein and virus particles with 8 hemagglutination units, incubated at room temperature for 45 minutes, can inhibit the hemagglutination activity of the virus particles, while the control group BSA has no Hemagglutination inhibitory activity, the results are shown in Table 1, figure 1 shown.
[0044] Table 1 The hemagglutination inhibitory titer of recombinant membrane moesin MSN protein to RHDV (unit: μ g)
[0045]
Embodiment 2
[0046] Example 2 Moesin MSN protein virus neutralization test
[0047] Take 10 RHDV antibody-negative rabbits and divide them into two groups, 5 rabbits in each group. The first neutralization group: RHDV virions with 16 times the median lethal dose (LD50) were mixed with 56 μg of recombinant MSN protein, the mixture was incubated at room temperature for 60 minutes, and inoculated by oral or nasal drops. The second group of negative control group: direct inoculation of 16 times half lethal dose (LD50) of RHDV virus particles through oral cavity and nasal drop. During the observation period of 8 days, all the 5 rabbits in the neutralization group survived and were healthy in appearance, and there was no abnormality in each organ (such as figure 2 Shown), the human "O" red blood cell agglutination titer of the liver tissue grinding liquid is 20, which is judged as negative. 5 rabbits in the negative control group died one after another within 3 days, and the human "O" hemoglo...
experiment example 1
[0050] Experimental example 1 The protein that interacts with the structural protein VP60 of rabbit hemorrhagic disease virus was obtained from the cDNA library of rabbit liver tissue
[0051] The yeast two-hybrid method was used to catch the protein interacting with the VP60 protein of rabbit hemorrhagic disease virus. The oligonucleotide primers used in this study are shown in Table 3:
[0052] Primer name
Primer sequence
VP60 upstream primer
5`-CCGGAATTCATGGAGGGCAAAACCCGCACA-3`(EcoR I)
VP60 downstream primer
5`-ACGCGTCGACTTATCAGACATAAGAAAAGC-3`(Sal I)
CDSIII Primer
5′-ATTCTAGAGGCCGAGGCGGCCGACATG-d(T)30VN-3′)*
SMART III Oligo
5′-AAGCAGTGGTATCAACGCAGAGTGGCCATTATGGCCGGG-3′)
5′PCR Primer
5′-TTCCACCCAAAGCAGTGGTATCAACGCAGAGTGG-3′
3′PCR Primer
5′-GTATCGATGCCCACCCTCTAGAGGCCGAGGCGGCCGACA-3′
AD-5`primer
5`-CTATTCGATGATGAAGATACCCCCACCAAACCC-3`
AD-3`primer
5`-GTGAACTTGCGGGGTTTTTCAGTATCTAC...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com